Neogen (NEOG) Shares Outstanding (Diluted) (2010 - 2026)
Neogen (NEOG) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.29 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 393.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 968.53 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 873.00 Mn |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn | 217.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 217.70 Mn |
| Nov 30, 2025 | 217.41 Mn |
| Aug 31, 2025 | 217.33 Mn |
| May 31, 2025 | 216.89 Mn |
| Feb 28, 2025 | 217.03 Mn |
| Nov 30, 2024 | 216.81 Mn |
| Aug 31, 2024 | 216.70 Mn |
| May 31, 2024 | 216.48 Mn |
| Feb 29, 2024 | 216.60 Mn |
| Nov 30, 2023 | 216.41 Mn |
| Aug 31, 2023 | 216.85 Mn |
| May 31, 2023 | 188.88 Mn |
| Feb 28, 2023 | 216.40 Mn |
| Nov 30, 2022 | 216.13 Mn |
| Aug 31, 2022 | 107.86 Mn |
| May 31, 2022 | 108.02 Mn |
| Feb 28, 2022 | 108.13 Mn |
| Nov 30, 2021 | 108.12 Mn |
| Aug 31, 2021 | 108.11 Mn |
| May 31, 2021 | 107.12 Mn |